Congress Asset Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $343K | Buy |
|
|||||
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $433K | Sell |
|
|||||
|
2024
Q4 | $805K | Sell |
|
|||||
|
2024
Q3 | $85.5M | Sell |
|
|||||
|
2024
Q2 | $91.5M | Sell |
|
|||||
|
2024
Q1 | $123M | Sell |
|
|||||
|
2023
Q4 | $110M | Sell |
|
|||||
|
2023
Q3 | $91.8M | Buy |
|
|||||
|
2023
Q2 | $98.2M | Buy |
|
|||||
|
2023
Q1 | $94.2M | Buy |
|
|||||
|
2022
Q4 | $98.6M | Sell |
|
|||||
|
2022
Q3 | $94.9M | Buy |
|
|||||
|
2022
Q2 | $98.8M | Buy |
|
|||||
|
2022
Q1 | $129M | Buy |
|
|||||
|
2021
Q4 | $163M | Sell |
|
|||||
|
2021
Q3 | $185M | Sell |
|
|||||
|
2021
Q2 | $174M | Sell |
|
|||||
|
2021
Q1 | $155M | Sell |
|
|||||
|
2020
Q4 | $149M | Sell |
|
|||||
|
2020
Q3 | $139M | Sell |
|
|||||
|
2020
Q2 | $110M | Sell |
|
|||||
|
2020
Q1 | $81.4M | Sell |
|
|||||
|
2019
Q4 | $104M | Sell |
|
|||||
|
2019
Q3 | $90.7M | Sell |
|
|||||
|
2019
Q2 | $99.7M | Sell |
|
|||||
|
2019
Q1 | $109M | Sell |
|
|||||
|
2018
Q4 | $87M | Sell |
|
|||||
|
2018
Q3 | $109M | Sell |
|
|||||
|
2018
Q2 | $92.9M | Sell |
|
|||||
|
2018
Q1 | $88.7M | Buy |
|
|||||
|
2017
Q4 | $84.4M | Buy |
|
|||||
|
2017
Q3 | $81.7M | Buy |
|